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OPINION
                    
COWEN, Circuit Judge.
This securities class action was brought on behalf of investors who purchased
securities issued by The Great Atlantic & Pacific Tea Company (“A&P”) during the
period between May 19, 1999 and July 5, 2002, inclusive (“the class period”).  The lead
plaintiffs appeal the District Court’s Order dismissing the Amended Complaint for failing
to adequately plead scienter.  We find no error in the District Court’s analysis and will
affirm.
Background
As we only write for the parties, we will briefly explain the relevant facts
underlying this appeal.  A&P is a Montvale, New Jersey company which operates various
food and drug stores, conventional supermarkets, and limited assortment food stores in
the United States and Canada.  During the years preceding and including the class period,
A&P filed reports with the Securities & Exchange Commission (“SEC”), which misstated
the amounts of vendor allowances, income from subleased stores, and self insurance
reserve accounts.  The financial statements included representations from management
that they had been prepared in accordance with Generally Accepted Accounting
Procedures (“GAAP”).  According to the Amended Complaint, however, these
misstatements occurred as a result of violations of GAAP.
4On March 28, 2000, Christian Haub, the CEO and Chairman of the Board of
Directors of A&P issued a press release regarding a detailed study of A&P’s business
processes and infrastructure, in which A&P compared itself to other leading companies,
both inside and outside the supermarket industry.  The press release indicated that A&P’s
“Project Great Renewal” would improve profitability over the next four years.  In various
conference calls with the market, the individual defendants made various representations
that the balance sheets were being strengthened and profitability was increasing.
On May 24, 2002, A&P announced that it would delay the filing of its annual
report in order to investigate “improper acts occurring in certain of its operating regions
related to the ‘appropriate timing for the recognition of allowances and the accounting for
inventory.’”  (App. at 72.)  A&P also requested an extension for filing its annual report
from the SEC, explaining that it was investigating “certain irregularities relating to the
appropriate timing for the recognition of vendor allowances and the accounting for
inventory.”  (Id.)  On July 5, 2002, A&P filed its annual report, in which it restated its
income statements from fiscal years 1999 and 2000, and the quarterly income statements
from the first three quarters of fiscal year 2001.  A&P issued a press release explaining
that it had discovered certain irregularities relating to vendor allowances, which had
prompted it to review all of its accounting procedures.  A&P fired at least nine high level
employees within days of the restatement.  Three months after the restatement, another
high level employee resigned.
5On June 5, 2002, Leonard Brody filed this action on behalf of himself and
investors like him.  The District Court consolidated Brody’s action with several others,
appointed Brody and four others as lead plaintiffs, and permitted the filing of an amended
complaint.  The complaint alleges that A&P and several of its corporate officers and high-
level employees (“the individual defendants”) knowingly issued false statements about its
business, in violation of Section 10(b) of the Securities and Exchange Act and Securities
Exchange Commission Rule 10b-5.  It also alleges that certain of the individual
defendants could be held liable for these actions as “controlling persons” under Section
20(a) of the Exchange Act.  A&P filed a motion to dismiss the amended complaint,
arguing, inter alia, that it failed to adequately plead scienter.  The District Court granted
A&P’s motion and Brody now appeals.
Discussion
We exercise plenary review over the District Court’s decision to grant a motion to
dismiss under Rule 12(b)(6).  Broselow v. Fisher, 319 F.3d 605, 607 (3d Cir. 2003).  We
must accept as true all well-pleaded facts alleged in the complaint, and draw all
reasonable inferences in favor of the non-moving party.  In re Rockefeller Center
Properties, Inc. Sec. Litig., 311 F.3d 198, 215 (3d Cir. 2002).  A motion to dismiss may
only be granted when it appears beyond doubt that the plaintiffs can prove no set of facts
that would entitle them to relief.  Id.  We are not required, however, to credit bald
assertions or legal conclusions.  Id.  We also exercise plenary review over the District
6Court’s interpretation of federal securities laws.  Id.  
Section 10(b) of the Securities and Exchange Act makes it unlawful “to use or
employ, in connection with the purchase or sale of any security registered on a national
securities exchange . . . any manipulative or deceptive device or contrivance in
contravention of such rules and regulations as the Commission may prescribe as
necessary or appropriate in the public interest or for the protection of investors.”  15
U.S.C. §78j(b).  Rule 10b-5, promulgated under Section 10(b), provides:
It shall be unlawful for any person, directly or indirectly, by the use of any
means or instrumentality of interstate commerce, or of the mails or of any
facility of any national securities exchange
. . . . 
(b) To make any untrue statement of a material fact or to omit to state a
material fact necessary in order to make the statements made, in the light of
the circumstances under which they were made, not misleading, or
(c) To engage in any act, practice, or course of business which operates or
would operate as a fraud or deceit upon any person,
 in connection with the purchase or sale of any security.
17 C.F.R. § 240.10b-5.  In order to state a claim under section 10b and Rule 10b-5,
plaintiffs must allege that the defendants “(1) made a misstatement or an omission of a
material fact (2) with scienter (3) in connection with the purchase or the sale of a security
(4) upon which the plaintiff reasonably relied and (5) that the plaintiff’s reliance was the
proximate cause of his or her injury.”  In re Ikon Office Solutions, Inc. Sec. Litig., 277
7F.3d 658, 666 (3d Cir. 2002). 
A securities fraud claim is subject to heightened pleading requirements.  Under
Federal Rule of Civil Procedure 9(b), “in all averments of fraud . . . the circumstances
constituting fraud . . . shall be stated with particularity.  Malice, intent, knowledge, and
other condition of mind of a person may be averred generally.”  Fed. R. Civ. P. 9(b).  The
Private Securities Litigation Reform Act (“PSLRA”), 15 U.S.C. § 78u, adds an additional
requirement, providing that “the complaint shall, with respect to each act or omission
alleged to violate this chapter, state with particularity facts giving rise to a strong
inference that the defendant acted with the required state of mind.”  15 U.S.C. §
78u-4(b)(2).  “[U]nless Plaintiffs in securities fraud actions allege facts supporting their
contentions of fraud with the requisite particularity mandated by Rule 9(b) and the
[PSLRA], they may not benefit from inferences flowing from vague or unspecific
allegations – inferences that may arguably have been justified under a traditional Rule
12(b)(6) analysis.”  In re Rockefeller Center, 311 F.3d at 224.  The failure to meet these
requirements will result in the dismissal of the complaint.  In re Advanta Corp. Sec.
Litig., 180 F.3d 525, 534-35 (3d Cir. 1999).
Plaintiffs may establish a “strong inference” that defendants acted with the
requisite scienter in one of two ways.  They may either allege facts that establish that
defendants had the motive and opportunity to commit fraud, or they may set forth facts
that constitute circumstantial evidence of reckless or conscious misbehavior.  Id. at 531. 
8As with the other allegations of fraud, the facts that give rise to a strong inference of
scienter must be alleged with particularity, meaning that plaintiffs must plead “the who,
what, where, when, and how:  the first paragraph of any newspaper story.”  Id. at 534
(quoting DiLeo v. Ernst & Young, 901 F.2d 624, 627 (7th Cir. 1990)).
The District Court found that Brody made six allegations regarding scienter: (1)
that A&P recognized vendor allowances in a manner that violated GAAP; (2) that A&P
recognized self-insurance reserves in a manner that violated GAAP; (3) that A&P
recognized closed-store subleases in a manner that violated GAAP; (4) a former senior
accounting manager stated that corporate account officers of A&P were aware of and
directed the methods used to recognize vendor allowances, self-insurance reserves, and
closed-store subleases; (5) A&P made a sale of over $275 million in senior notes during
the class period; and (6) after the discovery of the accounting irregularities, A&P fired
nine employees and Defendant Culligan resigned.  The District Court held that Brody
failed to plead any of these allegations with the particularity required to give rise to a
strong inference of scienter, and failed to connect any of these allegations to each other in
a manner permitting a strong inference of scienter.  
Brody argues that the District Court erred in failing to discuss whether A&P and
the individual defendants had the motive and opportunity to commit fraud.  He further
argues that such a motive existed, because A&P wished to facilitate the sale of the $275
million in Senior Notes to institutional investors.  The complaint alleges that A&P was
9able to sell these notes “on terms they would not otherwise have been able to receive had
the truth about its accounting violations been known.”  (App. at 94.)  The complaint did
not make specific allegations regarding the sale of the notes, however, and the District
Court was not required to credit this bald assertion.  “In every corporate transaction, the
corporation and its officers have a desire to complete the transaction, and officers will
usually reap financial benefits from a successful transaction.  Such allegations alone
cannot give rise to a ‘strong inference’ of fraudulent intent.”  GSC Partners CDO Fund v.
Washington, 368 F.3d 228, 237-38, (3d Cir. 2004).  
Brody also points to A&P’s desire to manage its earnings in order to meet analyst
and market expectations as a possible motive.  (Appellant’s Br. at 35.)  Again, this is a
general corporate motive, and is not sufficient to give rise to a strong inference of
scienter.  Because the complaint does not allege sufficient facts to establish motive, the
District Court did not err in discussing only the circumstantial evidence approach to
pleading scienter.  This approach requires a showing of either recklessness or conscious
wrongdoing.
Recklessness is not simply negligence.  “A reckless statement is a material
misrepresentation or omission ‘involving not merely simple, or even inexcusable
negligence, but an extreme departure from the standards of ordinary care, and which
presents a danger of misleading buyers or sellers that is either known to the defendant or
is so obvious that the actor must have been aware of it.’” Id. at 239 (quoting In re
10
Advanta, 180 F.3d at 535).  
When the alleged fraud is based on non-disclosure of facts, evidence that the
defendants had actual knowledge of the facts is sufficient to show scienter.  Id.  When the
alleged fraud is based on misrepresentation or false statements, however, it is not enough
to merely allege that defendants knew or must have known that their statements were
false.  Id.  Instead, plaintiffs must support their allegations with specific facts that lay out
the “who, what, where, when, and how.”  Id. (quoting In re Burlington Coat Factory Sec.
Litig., 114 F.3d 1410, 1422 (3d Cir. 1997)).  The scienter threshold will be met “if a
plaintiff can show – by whatever means – that defendants ‘did not have an honest belief
in the truth of their statements . . . .’” In re Ikon, 277 F.3d at 667 n.7 (quoting McLean v.
Alexander, 599 F.2d 1190, 1198 (3d Cir. 1979)).
The complaint alleges that A&P knew that the vendor allowances, self-insurance
reserves, and closed-store subleases were being recorded in a specific manner; these
allegations do not, however, show that A&P knew that the procedures used violated
GAAP.  Each of A&P’s financial disclosures contained boilerplate language that the
procedures used in the reports conformed with GAAP.  Brody points to this language as
proof that the GAAP violations were made with fraudulent intent.  Again, however, this
language does not show that A&P knew that its procedures violated GAAP prior to its
restatement of earnings in July 2002.  Finally, the former senior accounting manager
stated only that A&P knew of and directed the methods by which the vendor allowances
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were prematurely recognized.  There is no allegation that A&P knew that such
recognition violated GAAP.  As the District Court held, the allegations in the complaint
were not pled with sufficient particularity to establish scienter.
The allegations regarding the discharged employees are similarly inadequate. 
Other than a conclusory statement that nine employees were fired as a result of the
accounting irregularities, the complaint makes no specific allegations regarding how these
employees were involved in the accounting irregularities or whether they knew that the
accounting policies violated GAAP before the restatement was issued.  It does not appear
that A&P made any public statement linking the firings to the accounting irregularities. 
The complaint also alleges, without any factual basis, that Defendant Culligan resigned
from the company because of the accounting problems.  As Defendant Culligan’s
resignation took place three months after A&P’s restatement, it is unclear that the
resignation was at all related to the restatement.  Thus, the personnel changes do not
support a strong inference of scienter. 
Brody argues that the District Court did not consider the allegations as a whole in
determining that scienter had not been adequately pleaded.  It does not appear, however,
that the District Court made any error in its analysis.  The allegations in the complaint
simply do not meet the heightened standards required by Rule 9(b) and the PSLRA.  As
such, dismissal was proper.
Finally, the complaint alleges that certain of the individual defendants could be
12
held liable for A&P’s actions as “controlling persons” under Section 20(a) of the
Exchange Act.  Section 20(a) imposes liability on “any person who, directly or indirectly,
controls any person liable under any provision of this chapter or of any rule or regulation
thereunder . . .”  15 U.S.C. § 78t(a).  In order to show controlling person liability,
plaintiffs must demonstrate that one person controlled another person (or in this case, the
corporation) and that the controlled person is liable under the Exchange Act.  See In re
Alpharma, Inc. Sec. Litig., ___ F.3d ___, WL 1326013 (3d Cir. June 15, 2003).  In this
case, the controlled person is A&P.  Because plaintiffs failed to state a Rule 10b-5 claim
against A&P, and failed to allege any individual wrongdoing separate from the
allegations of ‘control,’ the Section 20(a) claim against the individual defendants fails as
well.
For the foregoing reasons, the judgment of the District Court entered on September
18, 2003, will be AFFIRMED.
